iifl-logo

Quant Healthcare Fund Regular G

Quant Healthcare Fund Regular G

Fund Name

Quant Mutual Fund

Scheme Name

Quant Healthcare Fund Regular G

AMC

Quant Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

27-Jun-2023

Fund Manager

Sandeep Tandon

Net Assets (Rs. cr)

340.56

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Quant Healthcare Fund Regular G - Nav Details

Nav Date

:  13-Feb-2026

NAV [Rs.]

:  14.694

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nil

Quant Healthcare Fund Regular G- NAV Chart

Quant Healthcare Fund Regular G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
3.52
0.92
-3.64
0.04
4.84
-
-
16.78
Category Avg
2.43
-0.42
-2.95
-1.37
6.04
22.96
15.21
13.04
Category Best
3.55
2.41
0.63
2.33
13.75
27.68
17.77
28.13
Category Worst
0.85
-4.44
-6.78
-5.95
-1.38
18.28
11.26
-6.27

Quant Healthcare Fund Regular G- Latest Dividends

No Records Found

Quant Healthcare Fund Regular G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
Medplus Health1,50,071

Out

InName Of The CompanyNo Of Shares
Cipla2,40,000
Samvardh. Mothe.12,36,150

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquityViyash ScientifiPharmaceuticals & Biotechnology8.83147712630.07
EquityZydus WellnessFood Products8.4464173028.76
EquitySMS Pharma.Pharmaceuticals & Biotechnology8.4490807128.74
EquityAurobindo PharmaPharmaceuticals & Biotechnology7.7021730026.24
EquityAster DM Health.Healthcare Services7.2444667124.66
EquityAlivus LifePharmaceuticals & Biotechnology6.9524629823.67
EquityPfizerPharmaceuticals & Biotechnology6.424795421.88
EquityAnthem BiosciencPharmaceuticals & Biotechnology5.8633355419.98
EquityAdani Enterp.Metals & Minerals Trading5.639499619.19
EquityDivi's Lab.Pharmaceuticals & Biotechnology3.622042412.35
EquityMedplus HealthRetailing3.5215007111.98
EquityConcord BiotechPharmaceuticals & Biotechnology2.88834729.80
EquityGland PharmaPharmaceuticals & Biotechnology1.52280765.18
EquityAdani Enterp. PP-/-0.52113991.79

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Quant Mutual Fund
Incorporation Date:
01-Dec-1995
Total Assets Managed (Cr.):
96,110.06
Trustee/s:
Quant Capital Trustee Lim, Mr. Deba Prasad Roy
Chairman:
NA
CEO / MD:
Mr. Sandeep Tandon
CIO:
NA
President:
NA
Director/s:
Mr. Deep Shukla, Mr.Vasav Sahgal, Sandeep Tandon, Mr. Laxmikant Gupta, Mr. Sandeep Tandon, Mr. Deep Shukla, Mr. Bhaskar Sharma
Compliance Officer/s:
Ms. Usha Lakshmi Raman
Investor Service Officer/s:
Mr. Shardul Gusain
Fund Manager/s:
Sandeep Tandon
Auditors:
M M Nissim & Co LLP

OTHER INFORMATION

Registered Office:
6th Floor, Sea Breeze Building, Appasaheb Marathe Marg, Prabhadevi Mumbai - 400025
Contact Nos:
022-62955000
Fax:
NA
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.